References for Controlling Metabolic Syndrome Risk1. Julie R Palmer et al. “Sugar-Sweetened Beverages and Incidence of Type 2 Diabetes Mellitus in African American Women” Arch Intern Med. 2008;168:1487-1492 2. Sabrina E. Feldeisen, Katherine L. “Tucker Nutritional strategies in the prevention and treatment of metabolic syndrome” Appl. Physiol. Nutr. Metab. 2007;32(1):46 DOI:10.1139/H06-101 3. Asghar M. et al. “Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats” Mol Cell Biochem. 2007;304(1-2):93-9. Epub 2007 May 15 4. Talpur N et al. “Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats” Mol Cell Biochem. 2003;252(1-2):369-77 5. Vladimir Badmaev, Muhammed Majeed, Anthony A. Conte. “Open field, physician controlled clinical evaluation of a botanical weight loss formula based on Garcinia cambogia derived (-)hydroxycitric acid” NutraCos. January/February 2002; 10-14. 6. Yanagita T, Nagao K “Functional lipids and the prevention of the metabolic syndrome” Asia Pac J Clin Nutr. 2008;17(1):189-91 7.Isabelle Demonty et al. “Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols1,2,3” Am J Clin Nutr. 2006;84(6):1534-42 8. Ebbesson SO “Fatty acid consumption and metabolic syndrome components: the GOCADAN study” J Cardiometab Syndr. 2007;2(4):244-9 9. V Vuksan et al. “Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial” Diabetes Care 1999;22(6):913-19 10. Hsiao-Ling Chen, RD, PhD et al. “Konjac Supplement Alleviated hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects—A Randomized Double-Blind Trial” J Am Col Nutr. 2003;22(1):36-42 11. Linarès E, Thimonier C, Degre M “The effect of NeOpuntia on blood lipid parameters--risk factors for the metabolic syndrome (syndrome X)” Adv Ther. 2007;24(5):1115-25
|